Ambeed.cn

首页 / 抑制剂/激动剂 / / / Epelsiban

Epelsiban {[allProObj[0].p_purity_real_show]}

货号:A762266 同义名: GSK 557296 Ambeed 开学季,买赠积分,赢豪礼

GSK 557296 is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor.

Epelsiban 化学结构 CAS号:872599-83-2
Epelsiban 化学结构
CAS号:872599-83-2
Epelsiban 3D分子结构
CAS号:872599-83-2
Epelsiban 化学结构 CAS号:872599-83-2
Epelsiban 3D分子结构 CAS号:872599-83-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Epelsiban 纯度/质量文件 产品仅供科研

货号:A762266 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 OX1 receptor OX2 receptor 其他靶点 纯度
SB-408124 ++

OX1 (membrane), Ki: 27 nM

OX1 (whole cell), Ki: 57 nM

{[allProObj[0].p_purity_real_show]}
SB-334867 free base {[allProObj[0].p_purity_real_show]}
Almorexant HCl +++

OX1 receptor, IC50: 6.6 nM

++++

OX2 receptor, IC50: 3.4 nM

{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Epelsiban 生物活性

描述 GSK 557296 is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor.

Epelsiban 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02794467 Adenomyosis Phase 2 Withdrawn(Study was prematurel... 展开 >>y discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.) 收起 << October 2016 United States, District of Col... 展开 >>umbia GSK Investigational Site Washington, DC, District of Columbia, United States, 20036 United States, Florida GSK Investigational Site West Palm Beach, Florida, United States, 33409 United States, Illinois GSK Investigational Site Champaign, Illinois, United States, 61820 United States, Louisiana GSK Investigational Site Mandeville, Louisiana, United States, 70471 GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Nebraska GSK Investigational Site Lincoln, Nebraska, United States, 68510 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89128 United States, New Jersey GSK Investigational Site Lawrenceville, New Jersey, United States, 08648 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27713 GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Ohio GSK Investigational Site Englewood, Ohio, United States, 45322 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15206 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 收起 <<
NCT02257359 Embryo Transfer Phase 1 Completed - United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT02213029 Embryo Transfer Phase 1 Terminated - United States, California ... 展开 >> GSK Investigational Site Glendale, California, United States, 91206 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<

Epelsiban 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.64mL

1.93mL

0.96mL

19.28mL

3.86mL

1.93mL

Epelsiban 技术信息

CAS号872599-83-2
分子式C30H38N4O4
分子量 518.647
别名 GSK 557296
运输蓝冰
存储条件

粉末

液体 -20°C:3-6个月-80°C:12个月

溶解度
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。